T. Rowe Price Associates
VRNA

T. Rowe Price Associates’s Verona Pharma VRNA Stock Holding History

T. Rowe Price Associates’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$169M Sell
1,789,513
-76,767
2025
Q1 		$118M Buy
1,866,280
+32,748
2024
Q4 		$85.2M Buy
1,833,532
+498,338
2024
Q3 		$38.4M Buy
1,335,194
+385,819
2024
Q2 		$13.7M Buy
+949,375